Clinical Trial Update: Evaluation of Neurocognitive Performance in Drug Substituted Patients Under Hepatitis C Therapy

View source ↗

Summary

The clinical trial evaluating neurocognitive performance in patients undergoing drug substitution during hepatitis C therapy was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Snippet

Sponsor: University of Wuerzburg | Conditions: Chronic Hepatitis C Infection | Status: WITHDRAWN